Short-term outcomes after minimally invasive oesophagectomy.

CONCLUSIONS: MIO was introduced at our department with acceptable morbidity and mortality rates and the short-term oncological result was not compromised. FUNDING: none. TRIAL REGISTRATION: The study was approved as a quality project by the Region of Southern Denmark (18/37355). PMID: 31315797 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31315797?dopt=Abstract

Source: Danish Medical Journal - July 20, 2019 Category: General Medicine Tags: Dan Med J Source Type: research